Literature DB >> 24059368

Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.

Bachir Taouli1, R Scott Johnson, Cristina H Hajdu, Marcel T H Oei, Miriam Merad, Herman Yee, Henry Rusinek.   

Abstract

OBJECTIVE: The objective of our study was to report our initial experience with dynamic contrast-enhanced MRI (DCE-MRI) for perfusion quantification of hepatocellular carcinoma (HCC) and surrounding liver. SUBJECTS AND METHODS: DCE-MRI of the liver was prospectively performed on 31 patients with HCC (male-female ratio, 26:5; mean age, 61 years; age range, 41-83 years). A dynamic coronal 3D FLASH sequence was performed at 1.5 T before and after injection of gadolinium-based contrast agent with an average temporal resolution of 3.8 seconds. Regions of interest were drawn on the abdominal aorta, portal vein, liver parenchyma, and HCC lesions by two observers in consensus. Time-activity curves were analyzed using a dual-input single-compartment model. The following perfusion parameters were obtained: arterial flow, portal venous flow, arterial fraction, distribution volume, and mean transit time (MTT).
RESULTS: Thirty-three HCCs (mean size, 3.9 cm; range, 1.1-12.6 cm) were evaluated in 26 patients. When compared with liver parenchyma, HCC showed significantly higher arterial hepatic blood flow and arterial fraction (p < 0.0001) and significantly lower distribution volume and portal venous hepatic blood flow (p < 0.0001-0.023), with no difference in MTT. Untreated HCCs (n = 16) had a higher arterial fraction and lower portal venous hepatic blood flow value than chemoembolized HCCs (n = 17, p < 0.04).
CONCLUSION: DCE-MRI can be used to quantify perfusion metrics of HCC and liver parenchyma and to assess perfusion changes after HCC chemoembolization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24059368      PMCID: PMC4144815          DOI: 10.2214/AJR.12.9798

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  38 in total

1.  Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.

Authors:  B E Van Beers; I Leconte; R Materne; A M Smith; J Jamart; Y Horsmans
Journal:  AJR Am J Roentgenol       Date:  2001-03       Impact factor: 3.959

2.  Assessment of hepatic perfusion parameters with dynamic MRI.

Authors:  R Materne; A M Smith; F Peeters; J P Dehoux; A Keyeux; Y Horsmans; B E Van Beers
Journal:  Magn Reson Med       Date:  2002-01       Impact factor: 4.668

3.  Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).

Authors:  Tao Jiang; Avinash Kambadakone; Naveen M Kulkarni; Andrew X Zhu; Dushyant V Sahani
Journal:  Invest Radiol       Date:  2012-01       Impact factor: 6.016

Review 4.  Chemoembolization for hepatocellular carcinoma.

Authors:  Jordi Bruix; Margarita Sala; Josep M Llovet
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway.

Authors:  Dipok Kumar Dhar; Hiroyuki Naora; Akira Yamanoi; Takashi Ono; Hitoshi Kohno; Hiroki Otani; Naofumi Nagasue
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

6.  Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.

Authors:  Laurence Annet; Roland Materne; Etienne Danse; Jacques Jamart; Yves Horsmans; Bernard E Van Beers
Journal:  Radiology       Date:  2003-09-11       Impact factor: 11.105

7.  Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.

Authors:  Bruno Morgan; Anne L Thomas; Joachim Drevs; Juergen Hennig; Martin Buchert; Asvina Jivan; Mark A Horsfield; Klaus Mross; Howard A Ball; Lucy Lee; William Mietlowski; Stefan Fuxuis; Clemens Unger; Ken O'Byrne; Andrew Henry; Graham R Cherryman; Dirk Laurent; Margaret Dugan; Dieter Marmé; William P Steward
Journal:  J Clin Oncol       Date:  2003-09-29       Impact factor: 44.544

8.  Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study.

Authors:  Jane Wang; Li-Tzong Chen; Yuk-Ming Tsang; Tsang-Wu Liu; Tiffany Ting-Fang Shih
Journal:  AJR Am J Roentgenol       Date:  2004-09       Impact factor: 3.959

Review 9.  Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.

Authors:  Anwar R Padhani
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

10.  Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit.

Authors:  Bernard E Van Beers; Roland Materne; Laurence Annet; Laurent Hermoye; Christine Sempoux; Frank Peeters; Anne M Smith; Jacques Jamart; Yves Horsmans
Journal:  Magn Reson Med       Date:  2003-04       Impact factor: 4.668

View more
  33 in total

1.  Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

Review 2.  Topics on quantitative liver magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Xiaoqi Wang; Peng Wu; Yajie Wang; Weibo Chen; Huijun Chen; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2019-11

3.  Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.

Authors:  Hersh Chandarana; Tobias Kai Block; Justin Ream; Artem Mikheev; Samuel H Sigal; Ricardo Otazo; Henry Rusinek
Journal:  Invest Radiol       Date:  2015-02       Impact factor: 6.016

Review 4.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.

Authors:  Brett Z Fite; Azadeh Kheirolomoom; Josquin L Foiret; Jai W Seo; Lisa M Mahakian; Elizabeth S Ingham; Sarah M Tam; Alexander D Borowsky; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  J Control Release       Date:  2017-04-07       Impact factor: 9.776

6.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

7.  Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Authors:  Bang-Bin Chen; Takamichi Murakami; Tiffany Ting-Fang Shih; Michiie Sakamoto; Osamu Matsui; Byung-Ihn Choi; Myeong-Jin Kim; Jeong Min Lee; Ren-Jie Yang; Meng-Su Zeng; Ran-Chou Chen; Ja-Der Liang
Journal:  Liver Cancer       Date:  2015-10-15       Impact factor: 11.740

8.  DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.

Authors:  Guido H Jajamovich; Wei Huang; Cecilia Besa; Xin Li; Aneela Afzal; Hadrien A Dyvorne; Bachir Taouli
Journal:  MAGMA       Date:  2015-12-08       Impact factor: 2.310

9.  Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?

Authors:  Nicole Wake; Hersh Chandarana; Henry Rusinek; Koji Fujimoto; Linda Moy; Daniel K Sodickson; Sungheon Gene Kim
Journal:  Magn Reson Imaging       Date:  2018-05-16       Impact factor: 2.546

Review 10.  DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.

Authors:  Bang-Bin Chen; Tiffany Ting-Fang Shih
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.